Cardinal Health Inc. (NYSE:CAH) stock surged on Thursday as the healthcare services company reported better-than-expected second-quarter financial results and raised its fiscal 2026 outlook.
The company reported adjusted earnings of $2.63 per share, beating the consensus of $2.35.
Sales increased 19% year over year to $65.63 billion, surpassing the consensus estimate of $64.14 billion. Adjusted operating earnings jumped 38% to $877 million.
Second quarter revenue for the Pharmaceutical and Specialty Solutions segment increased 19% to $60.7 billion, driven by brand and specialty pharmaceutical sales growth from existing and new customers.
The Pharmaceutical and Specialty Solutions segment profit increased 29% to $687 million, driven by contributions from brand and specialty products, the acquisition of MSO platforms, and positive generics program …